Login
Toggle navigation
Videos
Categories
Trending
The President Director of PT Solusi Tunas Pratama Tbk shares his career journey.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
President Director/CEO/Secy, Solusi Tunas Pratama Tbk PT.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Hassan Wahla, Telenav's Chief Commercial Officer, Delivers Insights on Autonomous Driving in Exclusive Interview | Telenav Inc
00:10:00
Microvision's mobile projector from 16 years ago garners 7.9K views, while Toyota's CEO claims Elon Musk will be astounded by their new innovation.
00:10:00
Addressing Mental Health in the Mining Industry: A Conversation with William Black
00:10:00
Key Highlights of the Interim Budget 2024-25: Fiscal Deficit, Tax Rates, and Capex Growth
00:10:00
Interview with Peter Espig of Nicola Mining on Projects and ESG Commitment
00:10:00
Day 4 of the 2024 Mining Indaba: Keamogetswe Mpofu's Mechanical Engineering PIT | DR. NOMBASA TSENGWA ,CHIEF EXECUTIVE OFFICER (MEMBER SOCIAL, ETHICS AND RESPONSIBILITY COMMITTEE), EXXARO RESOURCES LTD
00:10:00
Interview with Ole Henson, Head of Commodity Strategy at Saxo Bank: Insights on Gold and Silver Markets in 2023
00:10:00
Insight Partners has helped over 600 companies|George Mathew,Managing Director,Insight Partners
00:10:00
Unlocking Tomorrow: Exploring Windows 365 - The Future of Operating Systems | Brad Colledge, CEO, Data#3 Ltd DTL:ASX
00:10:00
Air Canada's Commitment to Net-Zero: Insights from CEO Michael Rousseau | Michael Rousseau, CEO, Air Canada.
00:10:00
Zhihao Zheng, CEO of Maoyan Entertainment, discusses the company's listing price and his ambitions for its future.
00:10:00
Nils Hübener, Head of Real Estate Investment at SEB Investment GmbH, foresees European occupier markets gaining momentum and emphasizes asset management as pivotal for investors shifting towards value-add strategies.